Anbio Biotechnology: eps_basic
| Value | {"per": "shares", "amount": 0.105, "concept": "us-gaap:EarningsPerShareBasic", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/309377a0-f84a-4a94-ae63-566ddcd83b5a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-035802Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001982708/eps-basic/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/309377a0-f84a-4a94-ae63-566ddcd83b5a
History
- no predecessors — first report